Massive Pulmonary Thromboembolism Demonstrated at Necropsy in Japanese Psychiatric Patients Treated With Neuroleptics Including Atypical Antipsychotics

Background There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital. Methods and Results Records of 1,1...

Full description

Saved in:
Bibliographic Details
Published inCirculation Journal Vol. 68; no. 9; pp. 850 - 852
Main Authors Hamanaka, Satoko, Nagai, Tomonori, Miyaoka, Hitoshi, Kurihara, Katsuyoshi, Kamijo, Yoshito, Soma, Kazui, Tanaka, Katsutoshi
Format Journal Article
LanguageEnglish
Published Japan The Japanese Circulation Society 01.09.2004
Subjects
Online AccessGet full text
ISSN1346-9843
1347-4820
DOI10.1253/circj.68.850

Cover

Abstract Background There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital. Methods and Results Records of 1,125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (CI), 1.82-9.78; p<0.01) and 10.49 (95% CI, 3.95-27.85; p<0.01), respectively. Conclusions Japanese women taking antipsychotic drugs may be at particular risk for PTE. (Circ J 2004; 68: 850 - 852)
AbstractList There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital. Records of 1,125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (CI), 1.82-9.78; p<0.01) and 10.49 (95% CI, 3.95-27.85; p<0.01), respectively. Japanese women taking antipsychotic drugs may be at particular risk for PTE.
There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital.BACKGROUNDThere may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital.Records of 1,125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (CI), 1.82-9.78; p<0.01) and 10.49 (95% CI, 3.95-27.85; p<0.01), respectively.METHODS AND RESULTSRecords of 1,125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (CI), 1.82-9.78; p<0.01) and 10.49 (95% CI, 3.95-27.85; p<0.01), respectively.Japanese women taking antipsychotic drugs may be at particular risk for PTE.CONCLUSIONSJapanese women taking antipsychotic drugs may be at particular risk for PTE.
Background There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden unexpected death determined by the Department of Legal Medicine of a Japanese university hospital. Methods and Results Records of 1,125 forensic autopsies (808 males, 317 females) performed during the study period for investigation of the cause of sudden unexpected death were reviewed and a logistic regression analysis was performed to explore whether age, gender, body mass index (BMI), and antipsychotic drug use were associated with fatal PTE. Among all records, 34 (3.0%; 14 males, 20 females) indicated the use of antipsychotic drugs and 28 (2.5%; 9 males, 19 females) indicated PTE as the cause of death. Of the 28 subjects who died from PTE, 8 had taken antipsychotic drugs (29%) and all were female. Female gender and antipsychotic drug use accounted for a significantly higher risk of PTE death with an odds ratio of 4.22 (95% confidence interval (CI), 1.82-9.78; p<0.01) and 10.49 (95% CI, 3.95-27.85; p<0.01), respectively. Conclusions Japanese women taking antipsychotic drugs may be at particular risk for PTE. (Circ J 2004; 68: 850 - 852)
Author Hamanaka, Satoko
Miyaoka, Hitoshi
Nagai, Tomonori
Kamijo, Yoshito
Tanaka, Katsutoshi
Soma, Kazui
Kurihara, Katsuyoshi
Author_xml – sequence: 1
  fullname: Hamanaka, Satoko
  organization: Departments of Psychiatry, School of Medicine
– sequence: 1
  fullname: Nagai, Tomonori
  organization: Legal Medicine, Kitasato University, School of Medicine
– sequence: 1
  fullname: Miyaoka, Hitoshi
  organization: Departments of Psychiatry, School of Medicine
– sequence: 1
  fullname: Kurihara, Katsuyoshi
  organization: Legal Medicine, Kitasato University, School of Medicine
– sequence: 1
  fullname: Kamijo, Yoshito
  organization: Emergency and Critical Care Medicine, School of Medicine
– sequence: 1
  fullname: Soma, Kazui
  organization: Emergency and Critical Care Medicine, School of Medicine
– sequence: 1
  fullname: Tanaka, Katsutoshi
  organization: Department of Occupational Mental Health, Kitasato University, Graduate School of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15329507$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtv1DAUhS3Uij5gxxp5xYpM7Thx4uWo5VHUli4GsYwc-6bjkWMH20GaX8LfxTNTGAmJhR_S_c69uudcoBPnHSD0hpIFLWt2pUxQmwVvF21NXqBzyqqmqNqSnOz_vBBtxc7QRYwbQkpBavESndGalaImzTn6dS9jND8BP8529E6GLV6tgx97D_lYE0d8A7kQU5AJNJYJP4AKfopbbBz-IifpIGZ53Kq1kSkYhR9lMuBSxKsAe9F3k9ZZNgdvYUpGRXzrlJ21cU94mbaTUdLipUtm2nXxO-IVOh2kjfD6-b1E3z5-WF1_Lu6-frq9Xt4VqmpYKpp60JoOTa-lzvsMwJhuaEkV1YNirWZUqrLsG0KYoKofBOecCdEDG3TVCs0u0btD3yn4HzPE1I0mKrA2r-Xn2HHe0pZRnsG3z-Dcj6C7KZgxu9X9sTID7w9AdifGAMMRId0uqW6fVMfbLieV8fIfXJmUjfMuO23s_0TLg2gTk3yCvxNkyJ5ZOMLicGXNsbaWoQPHfgPuTLTJ
CitedBy_id crossref_primary_10_1016_j_genhosppsych_2007_08_009
crossref_primary_10_1177_0025802413496408
crossref_primary_10_3999_jscpt_53_3
crossref_primary_10_1111_j_1472_8206_2007_00515_x
crossref_primary_10_1111_j_1538_7836_2011_04225_x
crossref_primary_10_1536_ihj_14_399
crossref_primary_10_1007_s40267_012_0002_z
crossref_primary_10_2165_00002018_200831080_00005
crossref_primary_10_1007_s00414_012_0670_1
crossref_primary_10_2165_11633920_000000000_00000
crossref_primary_10_2174_1570161118666200211114656
crossref_primary_10_5498_wjp_v11_i10_736
crossref_primary_10_1002_pds_2210
crossref_primary_10_1007_s40263_018_0495_7
crossref_primary_10_1177_2045125320982720
crossref_primary_10_1002_pds_1024
crossref_primary_10_1097_PAF_0b013e318219cb8f
crossref_primary_10_1016_j_encep_2012_06_007
crossref_primary_10_1016_j_jflm_2008_08_015
crossref_primary_10_7134_phlebol_17_01
crossref_primary_10_1186_s43045_020_00052_x
crossref_primary_10_1155_2013_718950
crossref_primary_10_1016_j_genhosppsych_2008_07_010
crossref_primary_10_1111_j_1601_5215_2012_00641_x
crossref_primary_10_1111_pcn_12001
crossref_primary_10_1024_1011_6877_22_1_17
crossref_primary_10_1097_YIC_0b013e3282fe9d44
crossref_primary_10_1017_S0790966700000884
crossref_primary_10_1089_cap_2013_0125
crossref_primary_10_1097_JCP_0b013e3181fbbb69
crossref_primary_10_1016_j_pharep_2017_12_003
crossref_primary_10_1186_s12888_025_06726_2
crossref_primary_10_1016_j_ajem_2013_12_038
crossref_primary_10_1007_s40264_013_0127_6
crossref_primary_10_2174_1389450121666200422084414
crossref_primary_10_1016_j_ajp_2022_103105
crossref_primary_10_1016_j_psychres_2020_113691
crossref_primary_10_1007_s40264_014_0170_y
crossref_primary_10_1111_j_1440_1819_2007_01773_x
crossref_primary_10_1016_j_legalmed_2007_09_003
crossref_primary_10_1517_14740330903117271
crossref_primary_10_1002_hup_633
crossref_primary_10_3918_jsicm_14_271
Cites_doi 10.1192/bjp.179.1.63
10.1097/01.jcp.0000088914.24613.51
10.1055/s-0028-1106111
10.1055/s-2007-1019607
10.1097/00001648-199711000-00014
10.1253/circj.66.257
10.1055/s-0037-1614935
10.1002/ajh.2830270408
10.7134/phlebol.14-3-189
10.1253/circj.67.46
10.1016/S0140-6736(00)02066-3
10.1016/0165-1781(83)90004-5
10.1016/S0140-6736(00)02784-7
10.1002/ajh.2830460233
10.1016/S0010-440X(65)80005-0
ContentType Journal Article
Copyright 2004 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2004 THE JAPANESE CIRCULATION SOCIETY
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1253/circj.68.850
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 852
ExternalDocumentID 15329507
10_1253_circj_68_850
article_circj_68_9_68_9_850_article_char_en
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
.GJ
29B
2WC
3O-
53G
5GY
5RE
6J9
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
OK1
OVT
P2P
RJT
RNS
RZJ
TKC
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
M~E
NPM
RYR
7X8
ID FETCH-LOGICAL-c473t-75fdd1f7bdad507fe33d7121c1dfc38d31ac22b700391cbf9666399be3fd489d3
ISSN 1346-9843
IngestDate Thu Jul 10 23:43:35 EDT 2025
Sat Sep 28 08:40:01 EDT 2024
Thu Apr 24 23:00:30 EDT 2025
Tue Jul 01 01:24:09 EDT 2025
Wed Sep 03 05:54:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c473t-75fdd1f7bdad507fe33d7121c1dfc38d31ac22b700391cbf9666399be3fd489d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/68/9/68_9_850/_article/-char/en
PMID 15329507
PQID 66818316
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_66818316
pubmed_primary_15329507
crossref_primary_10_1253_circj_68_850
crossref_citationtrail_10_1253_circj_68_850
jstage_primary_article_circj_68_9_68_9_850_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-09-01
PublicationDateYYYYMMDD 2004-09-01
PublicationDate_xml – month: 09
  year: 2004
  text: 2004-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2004
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 19. Kaiya H, Imai H, Muramatsu Y, Nozaki M, Fujimura H, Adachi S, et al. Platelet aggregation response in schizophrenia and prostaglandin E1. Psychiatry Res 1983; 9: 309-318.
1. Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999; 63: 825-827.
6. Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet 2000; 355: 1155-1156.
12. Lacika S, Cooper JP. Pulmonary embolus possibly associated with clozapine treatment. Can J Psychiatry 1999; 44: 396-397.
8. Ungvari G. Neuroleptic-related sudden death (proven or a mere hypothesis?). Pharmacopsychiatry 1980; 13: 29-33.
18. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003; 28: 55-68.
13. Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry 2001; 179: 63-66.
10. Zornberg GL, Jick H. Antipsychotic drug use and the risk of first-time idiopathic venous thromboembolism: A case-control study. Lancet 2000; 356: 1219-1223.
14. Davis S, Kern HB, Asokan R. Antiphospholipid antibodies associated with clozapine treatment. Am J Hematol 1994; 46: 166-167.
3. Tanifuji T, Kageyama N, Ro A, Hamamatsu A, Misawa S. A histo-pathological study of fatal pulmonary thromboembolism and deep vein thrombosis: In the study of deep vein thrombosis amoun forty patients with pulmonary thromboembolism Jpn J Phlebol 2003; 14: 189-195.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, edition IV. American Psychiatric Association, Washington D.C., 1994.
4. Kamijo Y, Soma K, Nagai T, Kurihara K, Ohwada T. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ J 2003; 67: 46-48.
9. Haefner H, Brehm I. Thromboembolic complications in neuroleptic treatment. Compr Psychiatry 1965; 6: 25-34.
15. Canoso RT, Oliviera RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis. Am J Hematol 1998; 27: 272-275.
7. Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Menten B, et al. Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 1998; 79: 511-516.
20. Grahmann H, Suchenwirth R. Thrombosis hazard in chlorpromazine and reserpine therapy of endogenous psychosis. Nervenarzt 1959; 30: 224-225.
16. Love RC. Novel versus conventional antipsychotic drugs. Pharmacotherapy 1996; 16: 6S-10S.
17. Wallaschofski H, Eigenthaler M, Kiefer M, Donne M, Hentschel B, Gertz HJ, et al. Hyperprolactinemina in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: Pilot study. J Clin Psychopharmacol 2003; 23: 479-483.
2. Nakamura M, Okada O, Sakuma M, Nakanishi N, Miyahara Y, Yamada N, et al. Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared with acute pulmonary thromboembolism: Results of a multicenter registry of the Japanese Society of Pulmonary Embolism Research. Circ J 2002; 66: 257-260.
11. Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology 1997; 8: 671-677.
21. Meier-Ewert K, Baumgart HH, Friedenberg P. Thromboembolism complications in neuro- and thymoleptic therapy. Dtsch Med Wochenschr 1967; 92: 2174-2178.
Tanifuji T, Kageyama N, Ro A, Hamam (3) 2003; 14
Canoso RT, Oliviera RM (15) 1998; 27
13
Vandenbroucke JP, Bertina RM, Holme (7) 1998; 79
Haefner H, Brehm I (9) 1965; 6
Lacika S, Cooper JP (12) 1999; 44
19
Ungvari G (8) 1980; 13
Davis S, Kern HB, Asokan R (14) 1994; 46
Wallaschofski H, Eigenthaler M, Kie (17) 2003; 23
Kinon BJ, Gilmore JA, Liu H, Halbre (18) 2003; 28
Grahmann H, Suchenwirth R (20) 1959; 30
5
Kamijo Y, Soma K, Nagai T, Kurihara (4) 2003; 67
6
Love RC (16) 1996; 16
HIROSE H (1) 1999; 63
Nakamura M, Okada O, Sakuma M, Naka (2) 2002; 66
Meier-Ewert K, Baumgart HH, Frieden (21) 1967; 92
Walker AM, Lanza LL, Arellano F, Ro (11) 1997; 8
10
References_xml – reference: 18. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003; 28: 55-68.
– reference: 8. Ungvari G. Neuroleptic-related sudden death (proven or a mere hypothesis?). Pharmacopsychiatry 1980; 13: 29-33.
– reference: 7. Vandenbroucke JP, Bertina RM, Holmes ZR, Spaargaren C, van Krieken JH, Menten B, et al. Factor V Leiden and fatal pulmonary embolism. Thromb Haemost 1998; 79: 511-516.
– reference: 10. Zornberg GL, Jick H. Antipsychotic drug use and the risk of first-time idiopathic venous thromboembolism: A case-control study. Lancet 2000; 356: 1219-1223.
– reference: 17. Wallaschofski H, Eigenthaler M, Kiefer M, Donne M, Hentschel B, Gertz HJ, et al. Hyperprolactinemina in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: Pilot study. J Clin Psychopharmacol 2003; 23: 479-483.
– reference: 9. Haefner H, Brehm I. Thromboembolic complications in neuroleptic treatment. Compr Psychiatry 1965; 6: 25-34.
– reference: 11. Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology 1997; 8: 671-677.
– reference: 14. Davis S, Kern HB, Asokan R. Antiphospholipid antibodies associated with clozapine treatment. Am J Hematol 1994; 46: 166-167.
– reference: 20. Grahmann H, Suchenwirth R. Thrombosis hazard in chlorpromazine and reserpine therapy of endogenous psychosis. Nervenarzt 1959; 30: 224-225.
– reference: 15. Canoso RT, Oliviera RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis. Am J Hematol 1998; 27: 272-275.
– reference: 5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, edition IV. American Psychiatric Association, Washington D.C., 1994.
– reference: 12. Lacika S, Cooper JP. Pulmonary embolus possibly associated with clozapine treatment. Can J Psychiatry 1999; 44: 396-397.
– reference: 13. Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry 2001; 179: 63-66.
– reference: 16. Love RC. Novel versus conventional antipsychotic drugs. Pharmacotherapy 1996; 16: 6S-10S.
– reference: 6. Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet 2000; 355: 1155-1156.
– reference: 21. Meier-Ewert K, Baumgart HH, Friedenberg P. Thromboembolism complications in neuro- and thymoleptic therapy. Dtsch Med Wochenschr 1967; 92: 2174-2178.
– reference: 2. Nakamura M, Okada O, Sakuma M, Nakanishi N, Miyahara Y, Yamada N, et al. Incidence and clinical characteristics of chronic pulmonary thromboembolism in Japan compared with acute pulmonary thromboembolism: Results of a multicenter registry of the Japanese Society of Pulmonary Embolism Research. Circ J 2002; 66: 257-260.
– reference: 1. Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999; 63: 825-827.
– reference: 3. Tanifuji T, Kageyama N, Ro A, Hamamatsu A, Misawa S. A histo-pathological study of fatal pulmonary thromboembolism and deep vein thrombosis: In the study of deep vein thrombosis amoun forty patients with pulmonary thromboembolism Jpn J Phlebol 2003; 14: 189-195.
– reference: 4. Kamijo Y, Soma K, Nagai T, Kurihara K, Ohwada T. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ J 2003; 67: 46-48.
– reference: 19. Kaiya H, Imai H, Muramatsu Y, Nozaki M, Fujimura H, Adachi S, et al. Platelet aggregation response in schizophrenia and prostaglandin E1. Psychiatry Res 1983; 9: 309-318.
– ident: 13
  doi: 10.1192/bjp.179.1.63
– volume: 23
  start-page: 479
  issn: 0271-0749
  year: 2003
  ident: 17
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/01.jcp.0000088914.24613.51
– volume: 92
  start-page: 2174
  issn: 0012-0472
  year: 1967
  ident: 21
  publication-title: Dtsch Med Wochenschr
  doi: 10.1055/s-0028-1106111
– ident: 5
– volume: 13
  start-page: 29
  issn: 0176-3679
  year: 1980
  ident: 8
  publication-title: Pharmacopsychiatry
  doi: 10.1055/s-2007-1019607
– volume: 63
  start-page: 825
  issn: 0047-1828
  issue: 10
  year: 1999
  ident: 1
  publication-title: Jpn Circ J
– volume: 8
  start-page: 671
  issn: 1044-3983
  year: 1997
  ident: 11
  publication-title: Epidemiology
  doi: 10.1097/00001648-199711000-00014
– volume: 66
  start-page: 257
  issn: 1346-9843
  year: 2002
  ident: 2
  publication-title: Circ J
  doi: 10.1253/circj.66.257
– volume: 44
  start-page: 396
  issn: 0706-7437
  year: 1999
  ident: 12
  publication-title: Can J Psychiatry
– volume: 79
  start-page: 511
  issn: 0340-6245
  year: 1998
  ident: 7
  publication-title: Thromb Haemost
  doi: 10.1055/s-0037-1614935
– volume: 27
  start-page: 272
  issn: 0361-8609
  year: 1998
  ident: 15
  publication-title: Am J Hematol
  doi: 10.1002/ajh.2830270408
– volume: 14
  start-page: 189
  year: 2003
  ident: 3
  publication-title: Jpn J Phlebol
  doi: 10.7134/phlebol.14-3-189
– volume: 67
  start-page: 46
  issn: 1346-9843
  year: 2003
  ident: 4
  publication-title: Circ J
  doi: 10.1253/circj.67.46
– volume: 28
  start-page: 55
  issn: 0306-4530
  year: 2003
  ident: 18
  publication-title: Psychoneuroendocrinology
– ident: 6
  doi: 10.1016/S0140-6736(00)02066-3
– volume: 16
  start-page: 6S
  issn: 0277-0008
  year: 1996
  ident: 16
  publication-title: Pharmacotherapy
– ident: 19
  doi: 10.1016/0165-1781(83)90004-5
– volume: 30
  start-page: 224
  issn: 0028-2804
  year: 1959
  ident: 20
  publication-title: Nervenarzt
– ident: 10
  doi: 10.1016/S0140-6736(00)02784-7
– volume: 46
  start-page: 166
  issn: 0361-8609
  year: 1994
  ident: 14
  publication-title: Am J Hematol
  doi: 10.1002/ajh.2830460233
– volume: 6
  start-page: 25
  issn: 0010-440X
  year: 1965
  ident: 9
  publication-title: Compr Psychiatry
  doi: 10.1016/S0010-440X(65)80005-0
SSID ssj0029059
Score 1.9567407
Snippet Background There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of...
There may be an increased risk of pulmonary thromboembolism (PTE) with antipsychotic drugs, so this association was investigated in autopsy cases of sudden...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 850
SubjectTerms Aged
Antidepressive Agents, Second-Generation - adverse effects
Antiphospholipid antibodies
Antipsychotic Agents - adverse effects
Atypical antipsychotic drugs
Autopsy
Death, Sudden
Female
Humans
Japan
Male
Medical Records
Middle Aged
Phenothiazines
Psychotic Disorders - drug therapy
Pulmonary Embolism - chemically induced
Pulmonary Embolism - mortality
Pulmonary thromboembolism
Title Massive Pulmonary Thromboembolism Demonstrated at Necropsy in Japanese Psychiatric Patients Treated With Neuroleptics Including Atypical Antipsychotics
URI https://www.jstage.jst.go.jp/article/circj/68/9/68_9_850/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/15329507
https://www.proquest.com/docview/66818316
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2004, Vol.68(9), pp.850-852
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKghAXxJvy9AFOKEsTJ07CDaFdVqvtcmmlcoocO1nSbZOqTQ7LH-HP8OOYSWw3BSoeh0ZV6rip5-t47HzzDSGv0sAXgnu54wUqdGCG8B3hsdwZcW-U-ilXYYC5w-NzfjL1T2fBbDD43mMtNXV6KL_-Nq_kf6wK58CumCX7D5a1ncIJeA_2hSNYGI5_ZeMxRL7I_Fk1C_hO5L9h1YNlWmXwWmD5C5UtMQBEPQiFeYtlhiW7Nm2y3ynMk1h_cst4LqTRWd10DHTDTW9VLxdIgJHI35KLps2FEfXVSqsN1IXO5zLseaN-UKylrhBmVSr2SVdgDGxvqn-hppb2dttFKS5Ft6NdV5eVnTbEspi3m7-fq80XcFZ2r1tcdHW3JxUMSLUu-o-wULNaM0s2zRVeuLMX4luyl3HfzOdOHHXCT8a_86iH47jnrKNO8vaXScRrK4FI-JnzQx4d6ma7Wt3nn5Lj6dlZMjmaTa6R614YtiSBjzNLMPLiUVuqz96TTruA3t_2-94JiG7MYU1wke1f7rRhz-QOua3XK_R9B767ZJCV98jNsWZk3CffNAapxSD9CYO0j0EqamowSIuSGnPTHgapwSDVGKSIQdrHILUYpAaDdBeDD8j0-Gjy4cTRxT4c6YesdsIgV8rNw1QJBWuUPGNMha7nSlflkkWKuUJ6Xhq2JQ1kmsMyHYPrNGO58qNYsYfkoKzK7DGhClbJPI4YTPQoHhXGGAOnoWIyjngWySF5Y0Y8kVoJHwuyLBJcEYN9ktY-CY8SsM-QvLatV50CzJ527zrj2VbaL2xbxd0BGm8_A4iDKxuSl8bgCfh3fGgHo181m4RzCKmZy4fkUYeD7U0EzIthqJ788dqn5Nb23_KMHNTrJnsOsXSdvmgh-wNAJ95H
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Massive+pulmonary+thromboembolism+demonstrated+at+necropsy+in+Japanese+psychiatric+patients+treated+with+neuroleptics+including+atypical+antipsychotics&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Hamanaka%2C+Satoko&rft.au=Kamijo%2C+Yoshito&rft.au=Nagai%2C+Tomonori&rft.au=Kurihara%2C+Katsuyoshi&rft.date=2004-09-01&rft.issn=1346-9843&rft.volume=68&rft.issue=9&rft.spage=850&rft_id=info:doi/10.1253%2Fcircj.68.850&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon